• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

4-[(7-溴-2-甲基-4-氧代-3H-喹唑啉-6-基)甲基丙-2-炔基氨基]-N-(3-吡啶甲基)苯甲酰胺(CB-30865)类似物作为烟酰胺磷酸核糖基转移酶(Nampt)的有效抑制剂。

Analogues of 4-[(7-Bromo-2-methyl-4-oxo-3H-quinazolin-6-yl)methylprop-2-ynylamino]-N-(3-pyridylmethyl)benzamide (CB-30865) as potent inhibitors of nicotinamide phosphoribosyltransferase (Nampt).

机构信息

Department of Medicinal Chemistry, Myrexis, Inc., Salt Lake City, Utah 84108, USA.

出版信息

J Med Chem. 2010 Dec 23;53(24):8734-46. doi: 10.1021/jm101145b. Epub 2010 Nov 16.

DOI:10.1021/jm101145b
PMID:21080724
Abstract

We have shown previously that the target of the potent cytotoxic agent 4-[(7-bromo-2-methyl-4-oxo-3H-quinazolin-6-yl)methyl-prop-2-ynylamino]-N-(3-pyridylmethyl)benzamide (CB38065, 1) is nicotinamide phosphoribosyltransferase (Nampt). With its cellular target known we sought to optimize the biochemical and cellular Nampt activity of 1 as well as its cytotoxicity. It was found that a 3-pyridylmethylamide substituent in the A region was critical to cellular Nampt activity and cytotoxicity, although other aromatic substitution did yield compounds with submicromolar enzymatic inhibition. Small unsaturated groups worked best in the D-region of the molecule, with 3,3-dimethylallyl providing optimal potency. The E region required a quinazolin-4-one or 1,2,3-benzotriazin-4-one group for activity, and many substituents were tolerated at C² of the quinazolin-4-one. The best compounds showed subnanomolar inhibition of Nampt and low nanomolar cytotoxicity in cellular assays.

摘要

我们之前已经表明,强效细胞毒性试剂 4-[(7-溴-2-甲基-4-氧代-3H-喹唑啉-6-基)甲基-丙-2-炔基氨基]-N-(3-吡啶甲基)苯甲酰胺(CB38065,1)的靶标是烟酰胺磷酸核糖转移酶(Nampt)。既然已经知道了它的细胞靶标,我们就试图优化 1 的生化和细胞 Nampt 活性及其细胞毒性。研究发现,A 区域中的 3-吡啶甲基酰胺取代基对于细胞 Nampt 活性和细胞毒性至关重要,尽管其他芳香取代基也能产生具有亚毫摩尔酶抑制作用的化合物。小分子不饱和基团在分子的 D 区域效果最佳,其中 3,3-二甲基烯丙基提供最佳的效力。E 区域需要喹唑啉-4-酮或 1,2,3-苯并三嗪-4-酮基团才能发挥作用,并且喹唑啉-4-酮的 C² 上可以容忍许多取代基。最好的化合物在细胞测定中显示出对 Nampt 的亚纳摩尔抑制作用和低纳摩尔级别的细胞毒性。

相似文献

1
Analogues of 4-[(7-Bromo-2-methyl-4-oxo-3H-quinazolin-6-yl)methylprop-2-ynylamino]-N-(3-pyridylmethyl)benzamide (CB-30865) as potent inhibitors of nicotinamide phosphoribosyltransferase (Nampt).4-[(7-溴-2-甲基-4-氧代-3H-喹唑啉-6-基)甲基丙-2-炔基氨基]-N-(3-吡啶甲基)苯甲酰胺(CB-30865)类似物作为烟酰胺磷酸核糖基转移酶(Nampt)的有效抑制剂。
J Med Chem. 2010 Dec 23;53(24):8734-46. doi: 10.1021/jm101145b. Epub 2010 Nov 16.
2
Chemical proteomics identifies Nampt as the target of CB30865, an orphan cytotoxic compound.化学蛋白质组学鉴定出Nampt是孤儿细胞毒性化合物CB30865的靶点。
Chem Biol. 2010 Jun 25;17(6):659-64. doi: 10.1016/j.chembiol.2010.05.008.
3
Carboranes increase the potency of small molecule inhibitors of nicotinamide phosphoribosyltranferase.碳硼烷提高烟酰胺磷酸核糖转移酶小分子抑制剂的效力。
J Med Chem. 2012 Aug 23;55(16):7290-4. doi: 10.1021/jm300740t. Epub 2012 Aug 13.
4
Structure-based design of substituted diphenyl sulfones and sulfoxides as lipophilic inhibitors of thymidylate synthase.基于结构设计取代二苯砜和亚砜作为胸苷酸合成酶的亲脂性抑制剂
J Med Chem. 1997 Feb 28;40(5):677-83. doi: 10.1021/jm960613f.
5
Fragment-based identification of amides derived from trans-2-(pyridin-3-yl)cyclopropanecarboxylic acid as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT).基于片段的方法鉴定了来源于反式-2-(吡啶-3-基)环丙烷羧酸的酰胺类化合物,它们是人源烟酰胺磷酸核糖转移酶(NAMPT)的有效抑制剂。
J Med Chem. 2014 Feb 13;57(3):770-92. doi: 10.1021/jm4015108. Epub 2014 Jan 22.
6
Structure-based design of lipophilic quinazoline inhibitors of thymidylate synthase.基于结构的胸苷酸合成酶亲脂性喹唑啉抑制剂设计
J Med Chem. 1996 Feb 16;39(4):904-17. doi: 10.1021/jm9502652.
7
Structural and biochemical analyses of the catalysis and potency impact of inhibitor phosphoribosylation by human nicotinamide phosphoribosyltransferase.人烟酰胺磷酸核糖转移酶对抑制剂磷酸核糖基化的催化作用及效力影响的结构与生化分析
Chembiochem. 2014 May 26;15(8):1121-30. doi: 10.1002/cbic.201402023. Epub 2014 May 5.
8
Nicotinamide phosphoribosyltransferase inhibitors, design, preparation, and structure-activity relationship.烟酰胺磷酸核糖基转移酶抑制剂的设计、制备及构效关系。
J Med Chem. 2013 Nov 27;56(22):9071-88. doi: 10.1021/jm4009949. Epub 2013 Nov 13.
9
A fluorometric assay for high-throughput screening targeting nicotinamide phosphoribosyltransferase.一种针对烟酰胺磷酸核糖转移酶的高通量筛选的荧光检测法。
Anal Biochem. 2011 May 1;412(1):18-25. doi: 10.1016/j.ab.2010.12.035. Epub 2011 Jan 4.
10
Fragment-based design of 3-aminopyridine-derived amides as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT).基于片段设计3-氨基吡啶衍生的酰胺作为人烟酰胺磷酸核糖基转移酶(NAMPT)的有效抑制剂。
Bioorg Med Chem Lett. 2014 Feb 1;24(3):954-62. doi: 10.1016/j.bmcl.2013.12.062. Epub 2013 Dec 21.

引用本文的文献

1
Channeling Nicotinamide Phosphoribosyltransferase (NAMPT) to Address Life and Death.引导烟酰胺磷酸核糖转移酶(NAMPT)来应对生死问题。
J Med Chem. 2024 Apr 25;67(8):5999-6026. doi: 10.1021/acs.jmedchem.3c02112. Epub 2024 Apr 5.
2
From Rate-Limiting Enzyme to Therapeutic Target: The Promise of NAMPT in Neurodegenerative Diseases.从限速酶到治疗靶点:烟酰胺磷酸核糖转移酶在神经退行性疾病中的前景
Front Pharmacol. 2022 Jul 12;13:920113. doi: 10.3389/fphar.2022.920113. eCollection 2022.
3
A human-based multi-gene signature enables quantitative drug repurposing for metabolic disease.
基于人类的多基因标志物可实现代谢疾病的药物重新定位定量分析。
Elife. 2022 Jan 17;11:e68832. doi: 10.7554/eLife.68832.
4
Structural Basis of Beneficial Design for Effective Nicotinamide Phosphoribosyltransferase Inhibitors.有效烟酰胺磷酸核糖基转移酶抑制剂的有益设计的结构基础。
Molecules. 2020 Aug 10;25(16):3633. doi: 10.3390/molecules25163633.
5
Secretion of one adipokine Nampt/Visfatin suppresses the inflammatory stress-induced NF-κB activity and affects Nampt-dependent cell viability in Huh-7 cells.一种脂肪因子烟酰胺磷酸核糖转移酶/内脏脂肪素的分泌可抑制炎症应激诱导的核因子κB活性,并影响Huh-7细胞中烟酰胺磷酸核糖转移酶依赖性细胞活力。
Mediators Inflamm. 2015;2015:392471. doi: 10.1155/2015/392471. Epub 2015 Feb 26.
6
CD73 protein as a source of extracellular precursors for sustained NAD+ biosynthesis in FK866-treated tumor cells.CD73 蛋白作为 FK866 处理的肿瘤细胞中持续 NAD+ 生物合成的细胞外前体来源。
J Biol Chem. 2013 Sep 6;288(36):25938-25949. doi: 10.1074/jbc.M113.470435. Epub 2013 Jul 23.